|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| A61K 39/395 | (2006.01) |
| (11) | Number of the document | 2493925 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10774095.3 |
| Date of filing the European patent application | 2010-10-26 | |
| (97) | Date of publication of the European application | 2012-09-05 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-23 |
| (46) | Date of publication of the claims translation | 2017-04-25 |
| (86) | Number | PCT/US2010/054148 |
| Date | 2010-10-26 |
| (87) | Number | WO 2011/056600 |
| Date | 2011-05-12 |
| (30) | Number | Date | Country code |
| 254982 P | 2009-10-26 | US | |
| 381287 P | 2010-09-09 | US |
| (72) |
TOWNE, Jennifer, E., US
CHENG, Janet, D., US
O`NEILL, Jason, C., US
ZHANG, Yu, US
SUN, Yu, US
CERNE, Heather, US
PIPER, Derek, E., US
KETCHEM, Randal, R., US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Žmogaus IL-23 antigeną surišantys baltymai |
| HUMAN IL-23 ANTIGEN BINDING PROTEINS |
| Payment date | Validity (years) | Amount | |
| 2023-10-09 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-10-26 |